{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:43:48Z","timestamp":1792183428121,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Assessment of adult T-cell leukemia\/lymphoma (ATL) development among human T-lymphotropic virus 1 (HTLV-1)-infected individuals (carriers) constitute a significant issue. A high HTLV-1 proviral load (PVL) in carriers has been used as a risk factor for ATL development and PVLs are considered to remain unchanged over time among carriers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This single-center analysis used a cohort from a prospective observational study of HTLV-1 carriers in Japan (JSPFAD). Carriers whose PVL was measured at least twice between October 2004 and March 2023 were included. We used trajectory analysis to construct a kinetic model of the PVL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Analysis of 1371 samples from 252 carriers revealed a slight but significant increase in the PVL with age (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Trajectory analysis of PVL kinetics classified the carriers into six groups, in three of which increased over time. When we applied the model to 15 carriers who subsequently developed ATL, 12 (80%) were classified into the highest PVL group, with an estimated 15-year ATL development of 47.5% (95% confidence interval: 20.4\u201374.2%). Notably, younger patients are at greater risk of developing ATL if their PVL values are comparable. Our risk estimation model is available online (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/atlriskpredictor.shinyapps.io\/ATL_risk_calculator\/\" ext-link-type=\"uri\">https:\/\/atlriskpredictor.shinyapps.io\/ATL_risk_calculator\/<\/jats:ext-link>).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study demonstrated that the PVLs increases over time, allowing for prospective risk estimation for ATL development. Further validation is needed to assess the validity of this model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Retrospectively registered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40364-025-00747-5","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T09:45:50Z","timestamp":1740563150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia\/lymphoma"],"prefix":"10.1186","volume":"13","author":[{"given":"Koji","family":"Jimbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Toriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Uchimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"747_CR1","doi-asserted-by":"publisher","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3. https:\/\/doi.org\/10.3389\/fmicb.2012.00388.","DOI":"10.3389\/fmicb.2012.00388"},{"key":"747_CR2","doi-asserted-by":"crossref","unstructured":"Uchiyama T, YoJ, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481\u201392.","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481"},{"issue":"12","key":"747_CR3","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77(12):7415\u20139. https:\/\/doi.org\/10.1073\/pnas.77.12.7415.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"747_CR4","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78(10):6476\u201380. https:\/\/doi.org\/10.1073\/pnas.78.10.6476.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"747_CR5","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79(6):2031\u20135. https:\/\/doi.org\/10.1073\/pnas.79.6.2031.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"747_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ana.410210203","volume":"21","author":"M Osame","year":"1987","unstructured":"Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987;21(2):117\u201322. https:\/\/doi.org\/10.1002\/ana.410210203.","journal-title":"Ann Neurol"},{"issue":"3","key":"747_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1349-7006.1992.tb00092.x","volume":"83","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992;83(3):236\u20139. https:\/\/doi.org\/10.1111\/j.1349-7006.1992.tb00092.x.","journal-title":"Jpn J Cancer Res"},{"key":"747_CR8","doi-asserted-by":"publisher","unstructured":"Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol. 2012;3. https:\/\/doi.org\/10.3389\/fmicb.2012.00322.","DOI":"10.3389\/fmicb.2012.00322"},{"issue":"24","key":"747_CR9","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126(24):2570\u20137. https:\/\/doi.org\/10.1182\/blood-2015-03-632489.","journal-title":"Blood"},{"key":"747_CR10","doi-asserted-by":"publisher","unstructured":"Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, et al. Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report. J Clin Oncol. 2019;37(8):677-+ https:\/\/doi.org\/10.1200\/jco.18.00501.","DOI":"10.1200\/jco.18.00501"},{"issue":"4","key":"747_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1182\/blood.2019004045","volume":"137","author":"LB Cook","year":"2021","unstructured":"Cook LB, Phillips AA. How I treat adult T-cell leukemia\/lymphoma. Blood. 2021;137(4):459\u201370. https:\/\/doi.org\/10.1182\/blood.2019004045.","journal-title":"Blood"},{"issue":"4","key":"747_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/s0092-8674(03)00881-x","volume":"115","author":"N Manel","year":"2003","unstructured":"Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell. 2003;115(4):449\u201359. https:\/\/doi.org\/10.1016\/s0092-8674(03)00881-x.","journal-title":"Cell"},{"key":"747_CR13","unstructured":"Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, et al. HTLV-I spreads between lymphocytes by virus-induced polarization of the cytoskeleton. AIDS Res Hum Retroviruses. 2003;19:S15-S."},{"key":"747_CR14","doi-asserted-by":"publisher","unstructured":"Gallo RC. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology. 2005;2. https:\/\/doi.org\/10.1186\/1742-4690-2-17.","DOI":"10.1186\/1742-4690-2-17"},{"issue":"1","key":"747_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm.2065","volume":"16","author":"AM Pais-Correia","year":"2010","unstructured":"Pais-Correia AM, Sachse M, Guadagnini S, Robbiati V, Lasserre R, Gessain A, et al. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med. 2010;16(1):83-U119. https:\/\/doi.org\/10.1038\/nm.2065.","journal-title":"Nat Med"},{"issue":"21","key":"747_CR16","doi-asserted-by":"publisher","first-page":"10683","DOI":"10.1128\/jvi.01009-06","volume":"80","author":"P Miyazato","year":"2006","unstructured":"Miyazato P, Yasunaga J, Taniguchi Y, Koyanagi Y, Mitsuya H, Matsuoka M. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common \u03b3-chain knockout mice. J Virol. 2006;80(21):10683\u201391. https:\/\/doi.org\/10.1128\/jvi.01009-06.","journal-title":"J Virol"},{"issue":"4","key":"747_CR17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/jmv.23227","volume":"84","author":"M Furtado","year":"2012","unstructured":"Furtado M, Andrade RG, Romanelli LCF, Ribeiro MA, Ribas JG, Torres EB, et al. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy\/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease. J Med Virol. 2012;84(4):664\u201371. https:\/\/doi.org\/10.1002\/jmv.23227.","journal-title":"J Med Virol"},{"issue":"2","key":"747_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/aid.2012.0132","volume":"29","author":"MA Demontis","year":"2013","unstructured":"Demontis MA, Hilburn S, Taylor GP. Human T Cell Lymphotropic Virus Type 1 Viral Load Variability and Long-Term Trends in Asymptomatic Carriers and in Patients with Human T Cell Lymphotropic Virus Type 1-Related Diseases. AIDS Res Hum Retroviruses. 2013;29(2):359\u201364. https:\/\/doi.org\/10.1089\/aid.2012.0132.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"747_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, et al. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998;4(6):586\u201393. https:\/\/doi.org\/10.3109\/13550289809114225.","journal-title":"J Neurovirol"},{"issue":"5","key":"747_CR20","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1086\/315088","volume":"180","author":"A Manns","year":"1999","unstructured":"Manns A, Miley WJ, Wilks RJ, Morgan OSC, Hanchard B, Wharfe G, et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis. 1999;180(5):1487\u201393. https:\/\/doi.org\/10.1086\/315088.","journal-title":"J Infect Dis"},{"issue":"8","key":"747_CR21","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211\u20139. https:\/\/doi.org\/10.1182\/blood-2009-12-257410.","journal-title":"Blood"},{"issue":"7","key":"747_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/jmv.22087","volume":"83","author":"MFR Grassi","year":"2011","unstructured":"Grassi MFR, Olavarria VN, Kruschewsky RD, Mascarenhas RE, Dourado I, Correia LCL, et al. Human T Cell Lymphotropic Virus Type 1 (HTLV-1) Proviral Load of HTLV-Associated Myelopathy\/Tropical Spastic Paraparesis (HAM\/TSP) Patients According to New Diagnostic Criteria of HAM\/TSP. J Med Virol. 2011;83(7):1269\u201374. https:\/\/doi.org\/10.1002\/jmv.22087.","journal-title":"J Med Virol"},{"key":"747_CR23","doi-asserted-by":"publisher","unstructured":"Cook LBM, Melamed A, Demontis MA, Laydon DJ, Fox JM, Tosswill JHC, et al. Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients. Retrovirology. 2016;13. https:\/\/doi.org\/10.1186\/s12977-015-0236-7.","DOI":"10.1186\/s12977-015-0236-7"},{"issue":"1","key":"747_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00042560-199909010-00012","volume":"22","author":"GP Taylor","year":"1999","unstructured":"Taylor GP, Tosswill JHC, Matutes E, Daenke S, Hall S, Bain BJ, et al. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr. 1999;22(1):92\u2013100. https:\/\/doi.org\/10.1097\/00042560-199909010-00012.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"747_CR25","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1086\/508899","volume":"194","author":"N Kwaan","year":"2006","unstructured":"Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, et al. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis. 2006;194(11):1557\u201364. https:\/\/doi.org\/10.1086\/508899.","journal-title":"J Infect Dis"},{"key":"747_CR26","doi-asserted-by":"publisher","unstructured":"Iwamoto N, Araki T, Umetsu A, Takatani A, Aramaki T, Ichinose K, et al. The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.887783.","DOI":"10.3389\/fimmu.2022.887783"},{"issue":"7","key":"747_CR27","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1182\/blood-2004-09-3646","volume":"106","author":"M Watanabe","year":"2005","unstructured":"Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood. 2005;106(7):2462\u201371. https:\/\/doi.org\/10.1182\/blood-2004-09-3646.","journal-title":"Blood"},{"issue":"7","key":"747_CR28","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1086\/428625","volume":"191","author":"G Tanaka","year":"2005","unstructured":"Tanaka G, Okayama A, Watanabe T, Aizawa S, Stuver S, Mueller N, et al. The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J Infect Dis. 2005;191(7):1140\u20137. https:\/\/doi.org\/10.1086\/428625.","journal-title":"J Infect Dis"},{"issue":"4","key":"747_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270\u201380. https:\/\/doi.org\/10.1038\/nrc2111.","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"747_CR30","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1182\/bloodadvances.2017005900","volume":"1","author":"S Firouzi","year":"2017","unstructured":"Firouzi S, Farmanbar A, Nakai K, Iwanaga M, Uchimaru K, Utsunomiya A, et al. Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia. Blood Adv. 2017;1(15):1195\u2013205. https:\/\/doi.org\/10.1182\/bloodadvances.2017005900.","journal-title":"Blood Adv"},{"issue":"11","key":"747_CR31","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1128\/JVI.02511-06","volume":"81","author":"M Miyazaki","year":"2007","unstructured":"Miyazaki M, Yasunaga J, Taniguchi Y, Tamiya S, Nakahata T, Matsuoka M. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5\u2019 long terminal repeat during oncogenesis. J Virol. 2007;81(11):5714\u201323. https:\/\/doi.org\/10.1128\/JVI.02511-06.","journal-title":"J Virol"},{"issue":"14","key":"747_CR32","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.1128\/JVI.02239-09","volume":"84","author":"J Fan","year":"2010","unstructured":"Fan J, Ma G, Nosaka K, Tanabe J, Satou Y, Koito A, et al. APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. J Virol. 2010;84(14):7278\u201387. https:\/\/doi.org\/10.1128\/JVI.02239-09.","journal-title":"J Virol"},{"issue":"25","key":"747_CR33","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2014-02-553602","volume":"123","author":"LB Cook","year":"2014","unstructured":"Cook LB, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L, et al. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia\/lymphoma. Blood. 2014;123(25):3925\u201331. https:\/\/doi.org\/10.1182\/blood-2014-02-553602.","journal-title":"Blood"},{"issue":"8","key":"747_CR34","doi-asserted-by":"publisher","first-page":"e1005120","DOI":"10.1371\/journal.ppat.1005120","volume":"11","author":"Y Mitagami","year":"2015","unstructured":"Mitagami Y, Yasunaga J, Kinosada H, Ohshima K, Matsuoka M. Interferon-\u03b3 Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice. PLoS Pathog. 2015;11(8): e1005120. https:\/\/doi.org\/10.1371\/journal.ppat.1005120.","journal-title":"PLoS Pathog"},{"issue":"1","key":"747_CR35","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41467-022-30029-9","volume":"13","author":"M Matsuo","year":"2022","unstructured":"Matsuo M, Ueno T, Monde K, Sugata K, Tan BJY, Rahman A, et al. Identification and characterization of a novel enhancer in the HTLV-1 proviral genome. Nat Commun. 2022;13(1):2405. https:\/\/doi.org\/10.1038\/s41467-022-30029-9.","journal-title":"Nat Commun"},{"key":"747_CR36","doi-asserted-by":"publisher","unstructured":"Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S, et al. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun. 2021;12(1). https:\/\/doi.org\/10.1038\/s41467-021-25101-9.","DOI":"10.1038\/s41467-021-25101-9"},{"issue":"4","key":"747_CR37","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/jha2.776","volume":"4","author":"K Jimbo","year":"2023","unstructured":"Jimbo K, Yamagishi M, Suzuki Y, Suzuki K, Mizukami M, Yokoyama K, et al. Progression of adult T-cell leukemia\/lymphoma from smoldering to acute type due to branched subclonal evolution. EJHaem. 2023;4(4):1188\u201390. https:\/\/doi.org\/10.1002\/jha2.776.","journal-title":"EJHaem"},{"key":"747_CR38","doi-asserted-by":"publisher","unstructured":"Taylor GP, Evans W, Rosadas C. High HTLV-1 Proviral Load Predates and Predicts HTLV-1-Associated Disease: Literature Review and the London Experience. Pathogens. 2024;13(7). https:\/\/doi.org\/10.3390\/pathogens13070553.","DOI":"10.3390\/pathogens13070553"},{"key":"747_CR39","doi-asserted-by":"publisher","unstructured":"Jimbo K, Kawamata T, Inamoto Y, Ito A, Yokoyama K, Sato A, et al. Flow cytometric profiles with CD7 and CADM1 in CD4+ T cells are promising indicators for prognosis of aggressive ATL. Blood\u00a0Adv. 2024;8:3760\u201370. https:\/\/doi.org\/10.1182\/bloodadvances.2024013089.","DOI":"10.1182\/bloodadvances.2024013089"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00747-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T09:45:55Z","timestamp":1740563155000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00747-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00747-5","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The participants provided written informed consent, in accordance with the principles set out in the Declaration of Helsinki. This study was approved by the Institutional Review Board of the Institute of Medical Science, The University of Tokyo (2019\u201372-0217; 2022\u201369-0203).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}